977
Views
118
CrossRef citations to date
0
Altmetric
Review

Disease burden of COPD in China: a systematic review

, , , &
Pages 1353-1364 | Published online: 27 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (22)

Xin Su, Haifeng Li, Fajun Li, Hongsen Liang, Li Wei, Donglei Shi, Junhang Zhang & Zhaojun Wang. (2023) Trends in the Burden of COPD Attributable to Ambient PM2.5 Exposure in China 1990−2019: An Age-Period-Cohort Analysis. Risk Management and Healthcare Policy 16, pages 69-77.
Read now
Weimin Li, Sami Z Daoud, Roopa Trivedi, Pradeep B Lukka, Eulalia Jimenez, Eduard Molins, Catherine Stewart, Pranob Bharali & Esther Garcia-Gil. (2023) The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2725-2735.
Read now
Xiaolong Zhang, Zhiyin Lei, Ying Wu, Yuanyuan Song, Xiaoling Wu, Bo Yang, Jianmei Fan, Shixu Feng, Liping Wu, Lingyan Li, Qin Dai, Zhen Zeng, Mei Feng & Tingting Zhang. (2023) Prevalence and Risk Factors for COPD in an Urbanizing Rural Area in Western China: A Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 459-468.
Read now
Rui Wang, Wei Zhang, Yuanyuan Li, Yuting Jiang, Hongqi Feng, Yang Du, Zhe Jiao, Li Lan, Xiaona Liu, Bingyun Li, Chang Liu, Xingbo Gu, Fang Chu, Yuncheng Shen, Chenpeng Zhu, Xinhua Shao, Simeng Tong & Dianjun Sun. (2022) Evaluation of Risk Factors for Chronic Obstructive Pulmonary Disease in the Middle-Aged and Elderly Rural Population of Northeast China Using Logistic Regression and Principal Component Analysis. Risk Management and Healthcare Policy 15, pages 1717-1726.
Read now
Jingyu Chen, Yanrong Yin, Yefa Zhang, Xiuquan Lin, Tiehui Chen, Ze Yang, Dengwei Wang & Wenling Zhong. (2022) Chronic Obstructive Pulmonary Disease Prevalence and Associated Risk Factors in Adults Aged 40 Years and Older in Southeast China: A Cross-Sectional Study During 2019–2020. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2317-2328.
Read now
Yiben Huang, Keke Ding, Zicong Dai, Jianing Wang, Binbin Hu, Xianjing Chen, Yage Xu, Beibei Yu, Lingzhi Huang, Chunyan Liu & Xiaodiao Zhang. (2022) The Relationship of Low-Density-Lipoprotein to Lymphocyte Ratio with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2175-2185.
Read now
Ying Lan, Nan Yang, Yirong Wang, Yujie Yang, Min Xu & Qin He. (2022) Cost-Effectiveness of Umeclidinium/Vilanterol versus Salmeterol/Fluticasone in Elderly Patients with Chronic Obstructive Pulmonary Diseases in China. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 609-619.
Read now
Yanjun Chen, Peijun Li, Jie Wang, Weibing Wu & Xiaodan Liu. (2022) Assessments and Targeted Rehabilitation Therapies for Diaphragmatic Dysfunction in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 457-473.
Read now
Lei Chen, Xianqiu Chen, Canghong Zhi, Xuan Li & Yang Hu. (2022) Levalbuterol vs. albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysis. Journal of Medical Economics 25:1, pages 966-973.
Read now
Haiyan Ge, Xuanqi Liu, Wenchao Gu, Xiumin Feng, Fengying Zhang, Fengfeng Han, Yechang Qian, Xiaoyan Jin, Beilan Gao, Li Yu, Hong Bao, Min Zhou, Shengqing Li, Zhijun Jie, Jian Wang, Zhihong Chen, Jingqing Hang, Jingxi Zhang & Huili Zhu. (2021) Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP. Journal of Inflammation Research 14, pages 3335-3348.
Read now
Taeyun Kim, Jehun Kim & Jun Hyeong Kim. (2021) Characteristics and Prevalence of Early Chronic Obstructive Pulmonary Disease in a Middle-Aged Population: Results from a Nationwide-Representative Sample. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3083-3091.
Read now
Meng Li, Kun Cheng, Keisun Ku, Junlei Li, Hao Hu & Carolina Oi Lam Ung. (2021) Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Record. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1677-1685.
Read now
Yide Wang, Zheng Li & Feng-sen Li. (2021) Development and Assessment of Prediction Models for the Development of COPD in a Typical Rural Area in Northwest China. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 477-486.
Read now
John R Hurst, Mohd Kashif Siddiqui, Barinder Singh, Precil Varghese, Ulf Holmgren & Enrico de Nigris. (2021) A Systematic Literature Review of the Humanistic Burden of COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1303-1314.
Read now
Li Li, Xuemei Zhong, Aifang Zheng, Chen JianKun, Ayiguzali A Budukadeer, Paierda Aini, Maimaitiaili Tuerxun, Mukeremu Yasen, Tao Ma, Jie Ren, Rukeyamu Semaiti, Chengxin Xie, Feifei Li, Mireban Rexiati, Lifeng Tang, Gulanbaier Abudurexiti, Dayong Zheng & Ji-Qiang Li. (2021) Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in Kashi Region, Northwestern China. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 655-663.
Read now
Shiyi Gong, Hao Hu, Kun Zhao & Ting Yang. (2021) Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 433-441.
Read now
Huimin Zhao, Bei Wu, Linglin Kong, Junyao Fan, Quan Wang, Jie Li & Jing Mao. (2020) Personal Growth and Associated Factors Among Patients with Chronic Obstructive Pulmonary Disease in China: A Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2977-2983.
Read now
Jia-xi Duan, Wei Cheng, Yu-qin Zeng, Yan Chen, Shan Cai, Xin Li, Ying-qun Zhu, Ming Chen, Mei-ling Zhou, Li-bing Ma, Qi-mi Liu & Ping Chen. (2020) Characteristics of Patients with Chronic Obstructive Pulmonary Disease Exposed to Different Environmental Risk Factors: A Large Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2857-2867.
Read now
Lirong Liang, Changwei Li, Ye Shen, Hengmo Rong, Hang Jing & Zhaohui Tong. (2020) Long-Term Trends in Hospitalization and Outcomes in Adult Patients with Exacerbation of Chronic Obstructive Pulmonary Disease in Beijing, China, from 2008 to 2017. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1155-1164.
Read now
Nanshan Zhong, Jinping Zheng, Sang Haak Lee, David A Lipson, Xin Du & Shunquan Wu. (2020) Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 809-819.
Read now
Zhihua Wang, Junling Zhao, Ting Wang, Xiaohui Du & Jungang Xie. (2019) Fine-particulate matter aggravates cigarette smoke extract–induced airway inflammation via Wnt5a–ERK pathway in COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 979-994.
Read now
Meng Li, Fengyan Wang, Rongchang Chen, Zhenyu Liang, Yumin Zhou, Yuqiong Yang, Shengqi Chen, Carolina Oi Lam Ung & Hao Hu. (2018) Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3349-3357.
Read now

Articles from other publishers (96)

Meifang Zhang, Xiaoli Mao, Fangli Li & Yunyan Xianyu. (2023) The effects of nurse‐led family pulmonary rehabilitation intervention on quality of life and exercise capacity in rural patients with COPD . Nursing Open 10:8, pages 5606-5615.
Crossref
Judith C.S. Holtjer, Lizan D. Bloemsma, Rosanne J.H.C.G. Beijers, Merel E.B. Cornelissen, Bart Hilvering, Laura Houweling, Roel C.H. Vermeulen, George S. Downward & Anke-Hilse Maitland-Van der Zee. (2023) Identifying risk factors for COPD and adult-onset asthma: an umbrella review. European Respiratory Review 32:168, pages 230009.
Crossref
Yu Zhou, Jie Chen, Fenghua Bai, Rubing Mo, Haihong Wu, Lei Zhang, Jie Zhao, Linhui Huang, Qi Lin, Chanyi He, Linsang Lin, Siguang Li, Tian Xie & Yipeng Ding. (2023) Suggestive evidence of genetic association of IL23R polymorphisms with chronic obstructive pulmonary disease risk in the Chinese population . The Journal of Gene Medicine 25:5.
Crossref
Ning Xie, Zheng Zheng, Qilian Yang, Man Li & Xiaofen Ye. (2023) Nurses in China lack knowledge of inhaler devices: A cross-sectional study. Frontiers in Pharmacology 14.
Crossref
Lisa Skär, Christel Borg, Margareta Emtner & Magnus Ekström. (2022) Thoughts on the end of life in patients with oxygen‐dependent chronic obstructive pulmonary disease: A qualitative interview study. Nursing Open 10:4, pages 2158-2164.
Crossref
Ao Lin, Chun Mao, Boqi Rao, Hongjun Zhao, Yunchao Wang, Guokang Yang, Haisheng Lei, Chenli Xie, Dongsheng Huang, Yibin Deng, Xuhui Zhang, Xinhua Wang & Jiachun Lu. (2023) Development and validation of nomogram including high altitude as a risk factor for COPD: A cross-sectional study based on Gansu population. Frontiers in Public Health 11.
Crossref
Hongyan Wang, Qin Liu, Linfeng Liu, Jun Cao, Qingfang Liang & Xiangeng Zhang. (2023) High-intensity interval training improves the outcomes of patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials. Respiratory Medicine 208, pages 107128.
Crossref
Hui Wang, Rui Meng, Xuelin Wang, Zhikang Si, Zekun Zhao, Haipeng Lu, Huan Wang, Jiaqi Hu, Yizhan Zheng, Jiaqi Chen, Ziwei Zheng, Yuanyu Chen, Yongzhong Yang, Xiaoming Li, Ling Xue, Jian Sun & Jianhui Wu. (2023) Development and Internal Validation of Risk Assessment Models for Chronic Obstructive Pulmonary Disease in Coal Workers. International Journal of Environmental Research and Public Health 20:4, pages 3655.
Crossref
Pengcheng Zhou, Jianli Ma, Wei Yu, Keling Chen, Wensheng Zhang & Jiang Zhou. (2023) Tiao-Bu-Fei-Shen Formula Improves Glucocorticoid Resistance of Chronic Obstructive Pulmonary Disease via Downregulating the PI3K-Akt Signaling Pathway and Promoting GRα Expression. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-17.
Crossref
Shuaixing Guo. (2023) Logistic Regression Analysis of Clinical Characteristics for Differentiation of Chronic Obstructive Pulmonary Disease Severity. Emergency Medicine International 2023, pages 1-8.
Crossref
Lu Dai, Bin-miao Liang & Xue-mei Ou. (2023) Predictive value of neutrophil-to-lymphocyte ratio and bilirubin levels in the readmission of acute exacerbation of chronic obstructive pulmonary disease. The American Journal of the Medical Sciences 365:2, pages 169-175.
Crossref
Jee Hyun Kang, Eunhye Jung, Eun-Ju Hong, Eun Bok Baek, Mee-Young Lee & Hyo-Jung Kwun. (2023) Effects of Cheonwangbosim-dan in a Mouse Model of Chronic Obstructive Pulmonary Disease: Anti-Inflammatory and Anti-Fibrotic Therapy. Applied Sciences 13:3, pages 1829.
Crossref
Sebastian Andone, Lénárd Farczádi, Silvia Imre, Zoltan Bajko, Anca Moțățăianu, Smaranda Maier, Laura Bărcuțean & Rodica Bălașa. (2023) Serum Fatty Acids Are Associated with a Higher Risk of Ischemic Stroke. Nutrients 15:3, pages 585.
Crossref
Le Cai, Xu-Ming Wang, Lan Liu, Yi Zhao & Allison Rabkin Golden. (2023) Socioeconomic differentials of trends in the prevalence and economic burden of chronic obstructive pulmonary disease in rural southwest China. BMC Public Health 23:1.
Crossref
Habibollah Azarbakhsh, Mahin Abdipour & Leila Moftakhar. (2023) Years of life lost due to chronic obstructive pulmonary disease in Khuzestan province during 2011–2019: A population-based study. Lung India 40:1, pages 37.
Crossref
颖 张. (2023) Research Progress of Chronic Obstructive Pulmonary Disease Complicated with Sarcopenia. Advances in Clinical Medicine 13:04, pages 6820-6825.
Crossref
Ruohua Yan, MyLinh Duong, Lap Ah Tse, Lu Yin, Sumathy Rangarajan, Salim Yusuf, Yan Hou, Zhengting Xu, Jinyuan Li & Wei Li. (2022) Regional differences in the contribution of smoking, dietary and cooking behaviours to airflow obstruction in China: A population‐based case–control study. Respirology 28:1, pages 37-46.
Crossref
Y. Zhou, F. Bai, X. Li, G. Zhou, X. Tian, G. Li, Y. Zhang, X. Zhou, D. Xu & Y. Ding. (2023) Genetic polymorphisms in MIR1208 and MIR5708 are associated with susceptibility to COPD in the Chinese population. Pulmonology 29:1, pages 6-12.
Crossref
Mimi Zhai, Qin Jiang, Sushun Liu, Jianhai Long, Dan Zhang, Chutong Ren, Yi Gong & Yamin Li. (2022) DALY trend and predictive analysis of COPD in China and its provinces: Findings from the global burden of disease study. Frontiers in Public Health 10.
Crossref
Ping Fan, Shu Zhang, Weiya Wang, Zongze Yang, Weiwei Tan, Shujun Li, Chenxing Zhu, Dan Hu, Xinran Zhou, Zixuan Tian, Yaxi Wang, Fang Liu, Wei Huang & Lei Chen. (2022) The design and implementation of natural population cohort study Biobank: A multiple-center project cooperation with medical consortia in Southwest China. Frontiers in Public Health 10.
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian, Hongyan Shang & Chen Wang. (2022) Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respiratory Research 23:1.
Crossref
Wenfeng Lu, Qi Tian, Ruijun Xu, Chenghui Zhong, Lan Qiu, Han Zhang, Chunxiang Shi, Yuewei Liu & Yun Zhou. (2022) Short-term exposure to ambient air pollution and pneumonia hospital admission among patients with COPD: a time-stratified case-crossover study. Respiratory Research 23:1.
Crossref
Ling Zhang, Ayiguli Maitinuer, Zhichuang Lian, Yafang Li, Wei Ding, Wenyi Wang, Chao Wu & Xiaohong Yang. (2022) Home based pulmonary tele-rehabilitation under telemedicine system for COPD: a cohort study. BMC Pulmonary Medicine 22:1.
Crossref
Jeong-eun Park, Luying Zhang, Yu-Fan Ho, Ge Liu, Rafael Alfonso-Cristancho, Afisi S. Ismaila & Zafar Zafari. (2022) Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study. Value in Health Regional Issues 32, pages 8-16.
Crossref
Zhaoqi Ma, Agisilaos Kourmatzis, Liam Milton-McGurk, Hak-Kim Chan, Dino Farina & Shaokoon Cheng. (2022) Simulating the effect of individual upper airway anatomical features on drug deposition. International Journal of Pharmaceutics 628, pages 122219.
Crossref
Lin Yuan, Ting Guo, Chengping Hu, Wei Yang, Xiaoli Tang, Hao Cheng, Yang Xiang, Xiangping Qu, Huijun Liu, Xiaoqun Qin, Ling Qin & Chi Liu. (2022) Clinical characteristics and gene mutation profiles of chronic obstructive pulmonary disease in non-small cell lung cancer. Frontiers in Oncology 12.
Crossref
Shuyi Zhang, Xianwang Lu, Xin Fang, Zihao Wang, Shihao Cheng & Jue Song. (2022) Cigarette smoke extract combined with LPS reduces ABCA3 expression in chronic pulmonary inflammation may be related to PPARγ/ P38 MAPK signaling pathway. Ecotoxicology and Environmental Safety 244, pages 114086.
Crossref
Aiping Ma, Guangdong Wang, Yan Du, Weixi Guo, Jiaxi Guo, Yi Hu, Dongyu Bai, Huiping Huang, Lianjin Zhuang, Jinhan Chen & Qun Liu. (2022) The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer. Frontiers in Oncology 12.
Crossref
Guixiang Zhao, Xuanlin Li, Siyuan Lei, Hulei Zhao, Hailong Zhang & Jiansheng Li. (2022) Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
Xiaoyue Song, Cynthia Hallensleben, Bo Li, Weihong Zhang, Zongliang Jiang, Hongxia Shen, Robbert J. J. Gobbens, Niels H. Chavannes & Anke Versluis. (2022) Illness Perceptions and Self-Management among People with Chronic Lung Disease and Healthcare Professionals: A Mixed-Method Study Identifying the Local Context. Healthcare 10:9, pages 1657.
Crossref
Yan Guo, Jianjun Bai, Xiaoxia Zhang, Qiman Jin, Yijun Liu & Chuanhua Yu. (2022) Secular Trends of Mortality and Years of Life Lost Due to Chronic Obstructive Pulmonary Disease in Wuhan, China from 2010 to 2019: Age-Period-Cohort Analysis. International Journal of Environmental Research and Public Health 19:17, pages 10685.
Crossref
Hui Pang, Zihan Pan, Rachel Adams, Eleanor Duncan, Chunhua Chi, Xia Kong, Peymané Adab, Kar Keung Cheng, Brendan G. Cooper, Jaime Correia-de-Sousa, Andrew P. Dickens, Alexandra Enocson, Amanda Farley, Nicola Gale, Kate Jolly, Sue Jowett, Mariam Maglakelidze, Tamaz Maghlakelidze, Sonia Martins, Alice Sitch, Katarina Stavrik, Raphael Stelmach, Alice Turner, Siân Williams & Rachel E. Jordan. (2022) Community lung health service design for COPD patients in China by the Breathe Well group. npj Primary Care Respiratory Medicine 32:1.
Crossref
Jing Zhao, Siyue Zhang, Ye Sun, Ning Zhou, Hui Yu, Hongxia Zhang & Dagong Jia. (2022) Wearable Optical Sensing in the Medical Internet of Things (MIoT) for Pervasive Medicine: Opportunities and Challenges. ACS Photonics 9:8, pages 2579-2599.
Crossref
Saeid Safiri, Kristin Carson-Chahhoud, Maryam Noori, Seyed Aria Nejadghaderi, Mark J M Sullman, Javad Ahmadian Heris, Khalil Ansarin, Mohammad Ali Mansournia, Gary S Collins, Ali-Asghar Kolahi & Jay S Kaufman. (2022) Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ, pages e069679.
Crossref
W. Hu, L. Fang, H. Zhang, R. Ni & G. Pan. (2022) Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China. Public Health 208, pages 89-97.
Crossref
Ivona Markelić, Iva Hlapčić, Andrea Čeri, Margareta Radić Antolic, Miroslav Samaržija, Sanja Popović-Grle, Andrea Vukić Dugac & Lada Rumora. (2022) Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease. Scientific Reports 12:1.
Crossref
Dichen Quan, Jiahui Ren, Hao Ren, Liqin Linghu, Xuchun Wang, Meichen Li, Yuchao Qiao, Zeping Ren & Lixia Qiu. (2022) Exploring influencing factors of chronic obstructive pulmonary disease based on elastic net and Bayesian network. Scientific Reports 12:1.
Crossref
Yunkun Chen & Wenbin Zhang. (2022) Zhuye Shigao Decoction Combined with Qingqi Huatan Pills in Alleviating the Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Phlegm-Heat Stagnating in the Lungs) via the IL-6-Mediated JAK1/STAT3 Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-12.
Crossref
Xiaodiao Zhang, Keke Ding, Xiaqi Miao, Jianing Wang, Binbin Hu, Jiamin Shen, Xueting Hu, Yage Xu, Beibei Yu, Tingting Tu, Aiju Lin, Xianjing Chen & Yiben Huang. (2022) Associations between bone mineral density and chronic obstructive pulmonary disease. Journal of International Medical Research 50:5, pages 030006052210946.
Crossref
Xiuli Zhang, Yaping Wang, Xiang He, Zerui Sun & Xuefeng Shi. (2022) Diagnosis of Chronic Obstructive Pulmonary Disease and Regulatory Mechanism of miR-149-3p on Alveolar Inflammatory Factors and Expression of Surfactant Proteins A (SP-A) and D (SP-D) on Lung Surface Mediated by Wnt Pathway. Computational Intelligence and Neuroscience 2022, pages 1-13.
Crossref
Weihong Han, Minghang Wang, Yang Xie, Huanrong Ruan, Hulei Zhao & Jiansheng Li. (2022) Prevalence of Pulmonary Embolism and Deep Venous Thromboembolism in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Yanchen Liu, Xiaoli Han, Xudong Cui, Xiangkai Zhao, Xin Zhao, Hongmiao Zheng, Benzhong Zhang & Xiaowei Ren. (2022) Association Between Air Pollutants and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Time Stratified Case‐Crossover Design With a Distributed Lag Nonlinear Model. GeoHealth 6:2.
Crossref
Felix Zulhendri, Conrad O. Perera, Steven Tandean, Rizky Abdulah, Herry Herman, Andreas Christoper, Kavita Chandrasekaran, Arfiza Putra & Ronny Lesmana. (2022) The Potential Use of Propolis as a Primary or an Adjunctive Therapy in Respiratory Tract-Related Diseases and Disorders: A Systematic Scoping Review. Biomedicine & Pharmacotherapy 146, pages 112595.
Crossref
Jianjun Bai, Yudi Zhao, Donghui Yang, Yudiyang Ma & Chuanhua Yu. (2022) Secular trends in chronic respiratory diseases mortality in Brazil, Russia, China, and South Africa: a comparative study across main BRICS countries from 1990 to 2019. BMC Public Health 22:1.
Crossref
漂 余. (2022) Study on the Mechanism of Jibei Kechuan Capsule’s Antitussive, Antiasthmatic and Expectorant Effects Based on Network Pharmacology. Hans Journal of Biomedicine 12:01, pages 18-26.
Crossref
Celia Gutiérrez Villegas, María Paz-Zulueta, Manuel Herrero-Montes, Paula Parás-Bravo & María Madrazo Pérez. (2021) Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Economics Review 11:1.
Crossref
M. D. Shen, L. R. Guo, Y. W. Li, R. T. Gao, X. Sui, Z. Du, L. Q. Xu, H. Y. Shi, Y. Y. Ni, X. Zhang, Y. Pang, W. Zhang, T. Z. Yu & F. Li. (2021) Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial. Trials 22:1.
Crossref
Xihua Mao, Chen Liang, Hongtao Niu, Fen Dong, Ke Huang, Yahong Chen, Kewu Huang, Qingyuan Zhan, Yaowen Zhang, Yin Huang, Ting Yang & Chen Wang. (2021) Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry. Respiratory Research 22:1.
Crossref
Jian-lan Hua, Xiao-fen Ye, Chun-ling Du, Ning Xie, Jie-qing Zhang, Man Li & Jing Zhang. (2021) Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma. BMC Pulmonary Medicine 21:1.
Crossref
Lanlan Zhu, Fei Xu, Xiuhua Kang, Jing Zhou, Qinqin Yao, Yang Lin & Wei Zhang. (2021) The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis. Molecular Medicine 27:1.
Crossref
Ye Yang, Lei Huang, Chongchong Tian & Bingjun Qian. (2021) Magnesium isoglycyrrhizinate inhibits airway inflammation in rats with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 21:1.
Crossref
Hang Fang, Min Zhang, Chongshun Zhao, Xia Yao, Haizhen Wang, Hailing Xia & Min Yu. (2021) Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients. Science Progress 104:4, pages 003685042110660.
Crossref
Jing Hou, Jun Wang, Jingyi Meng, Xiaoting Zhang, Yuanjing Niu, Jianping Gao, Yun’e Bai & Jiangtao Zhou. (2021) Zanthoxylum bungeanum Seed Oil Attenuates LPS-Induced BEAS-2B Cell Activation and Inflammation by Inhibiting the TLR4/MyD88/NF-κB Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-13.
Crossref
Zihan Pan, Andrew P Dickens, Chunhua Chi, Xia Kong, Alexandra Enocson, Brendan G Cooper, Peymané Adab, Kar Keung Cheng, Alice J Sitch, Sue Jowett, Rachel Adams, Jaime Correia-de-Sousa, Amanda Farley, Nicola K Gale, Kate Jolly, Mariam Maglakelidze, Tamaz Maglakelidze, Sonia M Martins, Katarina Stavrikj, Rafael Stelmach, Alice M Turner, Sian Williams & Rachel E Jordan. (2021) Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group. BMJ Open 11:9, pages e051811.
Crossref
Qianglin Zeng, Hao Wang, Ke Wang, Hui Zhou, Tao Wang & Fuqiang Wen. (2021) Eosinophilic phenotype was associated with better early clinical remission in elderly patients but not middle‐aged patients with acute exacerbations of COPD. International Journal of Clinical Practice 75:9.
Crossref
Ashwani Verma, Nachiket Gudi, Uday N Yadav, Manas Pratim Roy, Amreen Mahmood, Ravishankar Nagaraja & Pradeepa Nayak. (2021) Prevalence of COPD among population above 30 years in India: A systematic review and meta-analysis. Journal of Global Health 11.
Crossref
Thinni Nurul Rochmah, Indana Tri Rahmawati, Maznah Dahlui, Wasis Budiarto & Nabilah Bilqis. (2021) Economic Burden of Stroke Disease: A Systematic Review. International Journal of Environmental Research and Public Health 18:14, pages 7552.
Crossref
Carlos A. Torres-Duque, Felipe Severiche-Bueno & Mauricio González-García. 2021. Chronic Obstructive Pulmonary Disease - A Current Conspectus. Chronic Obstructive Pulmonary Disease - A Current Conspectus.
Teng Liu. (2021) miR-937 serves as an inflammatory inhibitor in cigarette smoke extract-induced human bronchial epithelial cells by targeting IL1B and regulating TNF-α/IL-17 signaling pathway. Tobacco Induced Diseases 19:July, pages 1-11.
Crossref
Xiaoling Yao, Xiaoyu Wang, Jing Yuan, Zhikang Huang, Dan Wu & Hongyan Xu. (2021) Benefits Conferred by Peer-Support Nursing Intervention to Pulmonary Function and Quality of Life in Nonsmoking Patients with COPD. Canadian Respiratory Journal 2021, pages 1-6.
Crossref
Shengnan Liu, Qiheng Zhao, Wenshuo Li, Xuetong Zhao & Kun Li. (2020) The Cost-Effectiveness of Pulmonary Rehabilitation for COPD in Different Settings: A Systematic Review. Applied Health Economics and Health Policy 19:3, pages 313-324.
Crossref
Qing Song, Ping Chen & Xiang-Ming Liu. (2021) The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD. Respiratory Research 22:1.
Crossref
Junjie Bi, Wei Yang, Ping Hao, Yongmei Zhao, Dan Wei, Yipeng Sun, Yuhua Lin, Meng Sun, Xuan Chen, Xuming Luo, Shanqun Li, Wei Zhang & Xiongbiao Wang. (2021) WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial. JMIR mHealth and uHealth 9:2, pages e23548.
Crossref
Fen Dong, Ke Huang, Xiaoxia Ren, Shiwei Qumu, Hongtao Niu, Yanyan Wang, Yong Li, Minya Lu, Xinshan Lin, Ting Yang, Jianjun Jiao & Chen Wang. (2021) Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016–2017: a retrospective study. BMJ Open 11:2, pages e040560.
Crossref
Bin Guo, Yan Wang, Lin Pei, Yan Yu, Feng Liu, Donghai Zhang, Xiaoxia Wang, Yi Su, Dingming Zhang, Bo Zhang & Hongjun Guo. (2021) Determining the effects of socioeconomic and environmental determinants on chronic obstructive pulmonary disease (COPD) mortality using geographically and temporally weighted regression model across Xi'an during 2014–2016. Science of The Total Environment 756, pages 143869.
Crossref
Xiaofang Ye, Zhitao Li, Xin Zhou, Xiaonan Ruan, Tao Lin, Ji Zhou, Dandan Yang, Sixu Yang, Xiaodan Chen, Kang Wu, Xiaonan Wang, Juzhong Ke, Xiaolin Liu, Li Peng & Li Luo. (2021) The Impact of a Health Forecasting Service on the Visits and Costs in Outpatient and Emergency Departments for COPD Patients — Shanghai Municipality, China, October 2019–April 2020. China CDC Weekly 3:23, pages 495-499.
Crossref
Xu Xu, Jingyun Li, Yuan Zhang & Luo Zhang. (2021) Arachidonic Acid 15-Lipoxygenase: Effects of Its Expression, Metabolites, and Genetic and Epigenetic Variations on Airway Inflammation. Allergy, Asthma & Immunology Research 13:5, pages 684.
Crossref
Winifred Ekezie, Alex Robert Jenkins, Ian Philip Hall, Catrin Evans, Rajendra Koju, Om Prakash Kurmi & Charlotte Emma Bolton. (2021) The burden of chronic respiratory diseases in adults in Nepal: A systematic review. Chronic Respiratory Disease 18, pages 147997312199457.
Crossref
Linlin Liu, Ying Luan, Ling Xiao, Ning Wang, Jing Wang & Zhaobo Cui. (2021) The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease. Medicine 100:16, pages e25547.
Crossref
Junman Wang, Peiyi Li & Jin Wen. (2020) Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis. BMC Health Services Research 20:1.
Crossref
Lu Xiao, Hongxia Duan, Peijun Li, Weibing Wu, Chunlei Shan & Xiaodan Liu. (2020) A systematic review and meta-analysis of Liuzijue in stable patients with chronic obstructive pulmonary disease. BMC Complementary Medicine and Therapies 20:1.
Crossref
Shuifang Chen, Yinan Yao, Shan Lu, Junjun Chen, Guangdie Yang, Lingfang Tu & Lina Chen. (2020) CircRNA0001859, a new diagnostic and prognostic biomarkers for COPD and AECOPD. BMC Pulmonary Medicine 20:1.
Crossref
Emily E. Hammond, Charles S. McDonald, Jørgen Vestbo & David W. Denning. (2020) The global impact of Aspergillus infection on COPD. BMC Pulmonary Medicine 20:1.
Crossref
Le Cai, Xu-Ming Wang, Lu-Ming Fan, Jing-Rong Shen, Ying-Nan Liu & Allison Rabkin Golden. (2020) Socioeconomic variations in chronic obstructive pulmonary disease prevalence, diagnosis, and treatment in rural Southwest China. BMC Public Health 20:1.
Crossref
Hechen Wang. (2020) Medical Expenditure Attributable to Chronic Obstructive Pulmonary Disease in China and Gender Differences: A Case Study on National Representative Data with Multivariate Linear and Logistic Regression. Medical Expenditure Attributable to Chronic Obstructive Pulmonary Disease in China and Gender Differences: A Case Study on National Representative Data with Multivariate Linear and Logistic Regression.
Evandro F. Fang, Chenglong Xie, Joseph A. Schenkel, Chenkai Wu, Qian Long, Honghua Cui, Yahyah Aman, Johannes Frank, Jing Liao, Huachun Zou, Ninie Y. Wang, Jing Wu, Xiaoting Liu, Tao Li, Yuan Fang, Zhangming Niu, Guang Yang, Jiangshui Hong, Qian Wang, Guobing Chen, Jun Li, Hou-Zao Chen, Lin Kang, Huanxing Su, Brian C. Gilmour, Xinqiang Zhu, Hong Jiang, Na He, Jun Tao, Sean Xiao Leng, Tanjun Tong & Jean Woo. (2020) A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks. Ageing Research Reviews 64, pages 101174.
Crossref
Longchuan Wu, Yu Chen, Jiao Yi, Yi Zhuang, Lei Cui & Chunhui Ye. (2020) Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation. BioMed Research International 2020, pages 1-12.
Crossref
Xing Yu, Gui‐Ping Zhu, Teng‐Fei Cai & Jian‐Yi Zheng. (2020) Establishment of risk prediction model and risk score for in‐hospital mortality in patients with AECOPD. The Clinical Respiratory Journal 14:11, pages 1090-1098.
Crossref
Liang Xie, Zilong Liu, Shengyu Hao, Qinhan Wu, Lidan Sun, Huixiu Luo, Ronghuan Yu, Xia Li, Xiaodan Wu & Shanqun Li. (2020) Assessment of knowledge, attitude, and practice towards pulmonary rehabilitation among COPD patients: A multicenter and cross-sectional survey in China. Respiratory Medicine 174, pages 106198.
Crossref
Ling-Hong Zhou, Ying-Kui Jiang, Ruo-Yu Li, Li-Ping Huang, Ching-Wan Yip, David W. Denning & Li-Ping Zhu. (2020) Risk-Based Estimate of Human Fungal Disease Burden, China. Emerging Infectious Diseases 26:9, pages 2137-2147.
Crossref
C. Raherison Semjen. (2020) Contaminación atmosférica y medioambiental y patología respiratoria. EMC - Tratado de Medicina 24:3, pages 1-9.
Crossref
Hyunji Choi & Taeyun Kim. (2020) Polyunsaturated fatty acids, lung function, and health-related quality of life in patients with chronic obstructive pulmonary disease. Yeungnam University Journal of Medicine 37:3, pages 194-201.
Crossref
Tommaso Lupia, Silvia Scabini, Simone Mornese Pinna, Giovanni Di Perri, Francesco Giuseppe De Rosa & Silvia Corcione. (2020) 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. Journal of Global Antimicrobial Resistance 21, pages 22-27.
Crossref
Jianlan Hua, Wei Zhang, Hui-fang Cao, Chun-ling Du, Jia-yun Ma, Yi-hui Zuo & Jing Zhang. (2020) Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial. BMJ Open 10:5, pages e034804.
Crossref
Yan Zeng, Yu Li, Hua Wei, Chan Xiong, Li Liao, Ti-wei Miao, Bing Mao & Juan-juan Fu. (2020) The Effects and Safety of Chinese Oral Herbal Paste on Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-16.
Crossref
Li Peng, Shaotan Xiao, Wei Gao, Yi Zhou, Ji Zhou, Dandan Yang & Xiaofang Ye. (2020) Short-term associations between size-fractionated particulate air pollution and COPD mortality in Shanghai, China. Environmental Pollution 257, pages 113483.
Crossref
Xuanlin Li, Yang Xie, Hulei Zhao, Hailong Zhang, Xueqing Yu & Jiansheng Li. (2020) Telemonitoring Interventions in COPD Patients: Overview of Systematic Reviews. BioMed Research International 2020, pages 1-9.
Crossref
Wei Bi, Yan Sun, Lin-qin Ma & Cai-jun Wu. (2020) Predictive role of interleukin-6 and CAT score in mechanical ventilation in patients with chronic obstructive pulmonary disease at the acute exacerbation stage in the emergency department. World Journal of Emergency Medicine 11:2, pages 93.
Crossref
Ru Chen, Ke-xin Wang, Xue Meng & Wen Zhou. (2020) Does benralizumab effectively treat chronic obstructive pulmonary disease? A protocol of systematic review and meta-analysis. Medicine 99:20, pages e20241.
Crossref
Xizi Du, Lin Yuan, Mengping Wu, Meichao Men, Ruoxi He, Leyuan Wang, Shuangyan Wu, Yang Xiang, Xiangping Qu, Huijun Liu, Xiaoqun Qin, Chengping Hu, Ling Qin & Chi Liu. (2019) Variable DNA methylation of aging-related genes is associated with male COPD. Respiratory Research 20:1.
Crossref
Marco Koch, Thomas Butt, Wudong Guo, Xue Li, Yirong Chen, Diana Tan & Gordon G. Liu. (2019) Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China. BMC Public Health 19:1.
Crossref
Cai Chen, Xuejian Liu, Xianfeng Wang, Wei Li, Wenxiu Qu, Leilei Dong, Xiyuan Li, Zhiqing Rui & Xueqing Yang. (2019) Risk of temperature, humidity and concentrations of air pollutants on the hospitalization of AECOPD. PLOS ONE 14:11, pages e0225307.
Crossref
Hong-hong Feng, Lu Mao, Kai Pan, Ling Zhang & Dong-sheng Rui. (2019) Association between F+1 polymorphism in a disintegrin and metalloprotease 33 (ADAM33) gene and chronic obstructive pulmonary disease susceptibility: An evidence-based meta-analysis. Gene 719, pages 144009.
Crossref
Yan Zeng, Yu Li, Hua Wei, Chan Xiong, Li Liao, Ti-wei Miao, Bing Mao & Juan-juan Fu. (2019) Chinese oral herbal paste for the treatment of stable chronic obstructive pulmonary disease. Medicine 98:28, pages e16444.
Crossref
Yidan Ren, Yi Zhang, Lixia Fan, Qinlian Jiao, Yunshan Wang & Qin Wang. (2019) The cullin4A is up-regulated in chronic obstructive pulmonary disease patient and contributes to epithelial-mesenchymal transition in small airway epithelium. Respiratory Research 20:1.
Crossref
Shuyue Xia, Jian Qu, Hui Jia, Wei He, Jing Li, Long Zhao, Mingqing Mao & Yan Zhao. (2019) Overexpression of Forkhead box C1 attenuates oxidative stress, inflammation and apoptosis in chronic obstructive pulmonary disease. Life Sciences 216, pages 75-84.
Crossref